TinaMMayerMD
Oncology • New Brunswick, NJGenitourinary Oncology, Hematologic Oncology
Associate Professor, Medicine, UMDNJ-Robert Wood Johnson Medical School
Dr. Mayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany Street
New Brunswick, NJ 08903Phone+1 732-235-2465Fax+1 732-235-8808
Summary
- Dr. Tina Mayer is an oncologist in New Brunswick, NJ and is affiliated with Robert Wood Johnson University Hospital. She received her medical degree from Weill Cornell Medical College of Cornell University and has been in practice since 2009. She specializes in genitourinary oncology.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Tufts Medical CenterResidency, Internal Medicine, 2003 - 2006
Weill Cornell MedicineClass of 2003
Certifications & Licensure
NJ State Medical License 2009 - 2025
CT State Medical License 2007 - 2008- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer Start of enrollment: 2011 Feb 01
- Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Start of enrollment: 2011 Jul 01
- 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy Start of enrollment: 2012 Dec 18
- Join now to see all
Publications & Presentations
PubMed
- PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.Philip Sutera, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson
The Prostate. 2024-10-01 - Expanding Geographical Access to Cancer Care in Botswana: Current Status and Future Prospects.Norman C Swart, Refeletswe Lebelonyane, Elane M Gutterman, Morongwa Legwaila, Tara M Friebel-Klingner
JCO Global Oncology. 2024-09-01 - 3 citationsPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
Press Mentions
Understanding Good Prostate Health for Cancer PreventionSeptember 8th, 2021- Rutgers Cancer Institute of New Jersey Experts Available for Comment During Men’s Health MonthJune 7th, 2021
- Study Offers Guidance for Improving Access to Oncology Drug Treatments in Sub-Saharan AfricaJuly 20th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
